ARVN
Arvinas Inc
NASDAQ · Pharmaceuticals
$13.48
+0.52 (+4.01%)
Open$13.14
Previous Close$12.96
Day High$13.62
Day Low$13.12
52W High$20.38
52W Low$5.90
Volume—
Avg Volume770.8K
Market Cap865.74M
P/E Ratio—
EPS$-0.80
SectorPharmaceuticals
Analyst Ratings
Buy
26 analysts
Price Target
+391.2% upside
Current
$13.48
$13.48
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 235.28M | 132.17M | 248.87M |
| Net Income | -177,663,667 | -89,824,897 | 33.41M |
| Profit Margin | -75.5% | -71.7% | 13.4% |
| EBITDA | -221,972,009 | -118,461,551 | 74.31M |
| Free Cash Flow | — | — | 30.36M |
| Rev Growth | +78.0% | +78.0% | +3.5% |
| Debt/Equity | 0.00 | 0.00 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |